Announcements Trials
Browse Landscape

Phase

Phase 1/2 3Phase 1 2

Status

Completed 3Recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Sarcoma 1

Conditions

Stomach Neoplasms 2Desmoid Tumors 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 142Gemcitabine 129Paclitaxel 125Radiotherapy 119Carboplatin 112Cisplatin 111pembrolizumab 110Nivolumab 106Docetaxel 90Rituximab 86Lenalidomide 77Dexamethasone 76Cytarabine 69Bevacizumab 64Fluorouracil 63Etoposide 63Oxaliplatin 62Filgrastim 59Peripheral Blood Stem Cell Transplantation 58Everolimus 58Capecitabine 58fludarabine phosphate 57Doxorubicin 56Temozolomide 55Prednisone 54Irinotecan 53Cetuximab 50fludarabine 48Ipilimumab 48Erlotinib Hydrochloride 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Completed × vactosertib × Clear all
NCT03724851 2025-03-25

Vactosertib in Combination with Pembrolizumab in Metastatic Colorectal or Gastric Cancer

MedPacto, Inc.

Phase 1/2 Completed
120 enrolled
Gastrointestinal

Stomach Neoplasms, Colorectal Neoplasms

NCT03698825 2024-12-09

TEW-7197 with Paclitaxel for the Treatment of Metastatic Gastric Cancer

MedPacto, Inc.

Phase 1/2 Completed
62 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03802084 2024-05-13

A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor

Yonsei University

Phase 1/2 Completed
24 enrolled
Sarcoma

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡